Previous studies have indicated that the covalent binding of acetaldehyde to proteins may be responsible for the hepatotoxicity of ethanol. These proposed studies will continue to explore this possibility and, in this regard, the following hypothesis has been formulated: During ethanol oxidation in the liver, acetaldehyde forms stable adducts via binding to """"""""reactive"""""""" lysines of preferential target proteins, resulting in selective functional impairment of these proteins and ultimately leading to liver cell injury. the initial objective is to clarify the chemistry of the interaction of acetaldehyde with proteins and to establish the mechanism of stable acetaldehyde-protein adduct formation. This information will be used to prepare appropriate antigens to produce and characterize antibodies that recognize relevant non-reduced stable adducts. These antibodies will then be used to develop a reliable assay for detecting acetaldehyde-protein adducts in the liver and other organs in rats chronically consuming ethanol.
The second aim will investigate whether lipid peroxide-derived aldehydes also form stable adducts with hepatic proteins during chronic ethanol administration. In this regard, livers of ethanol-fed rats will be assayed for the presence of malondialdehyde- and 4-hydroxynonenal-protein adducts as well as mixed adducts of acetaldehyde and these peroxide-derived aldehydes. Specific antibodies will again be generated in order to detect these adducts. In the third aim, experiments will determine the time-course levels of stable acetaldehyde and peroxide-derived aldehyde adducts in the livers and other organs of rats consuming ethanol over extended time periods. The lobular and subcellular distribution of these adducts in the liver will be determined, and selective protein targets of adduct formation will be identified. Correlation between the presence and/or distribution of these adducts and ethanol-induced hepatic changes and indices of liver will also be ascertained. A fourth specific aim will be concerned with establishing whether acetaldehyde-tubulin adduct formation results in altered microtubule function (i.e., impaired hepatic protein trafficking) in order to demonstrate a specific functional consequence of adduct formation to a specific target protein (i.e., tubulin) at the cellular level. finally, we intend to test the potential of three separate compounds (aminoguanidine, N-acetylcysteine or penicillamine) in their ability to alter levels of stable acetaldehyde adducts in the liver during chronic ethanol consumption and relate these findings to the ability of these agents to prevent or reduce the extent or severity of ethanol-induced liver injury. Based on these studies, the potential therapeutic role of these agents in the prevention and treatment of alcoholic liver disease can be evaluated. Overall, these proposed studies should provide valuable information concerning the basic molecular mechanisms of alcohol-induced hepatotoxicity.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA004961-14
Application #
2043078
Study Section
Biochemistry, Physiology and Medicine Subcommittee (ALCB)
Project Start
1993-08-01
Project End
1997-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
14
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Duryee, Michael J; Freeman, Thomas L; Willis, Monte S et al. (2005) Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins. Mol Pharmacol 68:1423-30
Duryee, Michael J; Willis, Monte S; Freeman, Thomas L et al. (2004) Mechanisms of alcohol liver damage: aldehydes, scavenger receptors, and autoimmunity. Front Biosci 9:3145-55
Tuma, Dean J; Casey, Carol A (2003) Dangerous byproducts of alcohol breakdown--focus on adducts. Alcohol Res Health 27:285-90
Duryee, Michael J; Klassen, Lynell W; Freeman, Thomas L et al. (2003) Chronic ethanol consumption impairs receptor-mediated endocytosis of MAA-modified albumin by liver endothelial cells. Biochem Pharmacol 66:1045-54
Kharbanda, Kusum K; Shubert, Kris A; Wyatt, Todd A et al. (2002) Effect of malondialdehyde-acetaldehyde-protein adducts on the protein kinase C-dependent secretion of urokinase-type plasminogen activator in hepatic stellate cells. Biochem Pharmacol 63:553-62
Kharbanda, K K; Todero, S L; Shubert, K A et al. (2001) Malondialdehyde-acetaldehyde-protein adducts increase secretion of chemokines by rat hepatic stellate cells. Alcohol 25:123-8
Schaffert, C S; Sorrell, M F; Tuma, D J (2001) Expression and cytoskeletal association of integrin subunits is selectively increased in rat perivenous hepatocytes after chronic ethanol administration. Alcohol Clin Exp Res 25:1749-57
Tuma, D J; Kearley, M L; Thiele, G M et al. (2001) Elucidation of reaction scheme describing malondialdehyde-acetaldehyde-protein adduct formation. Chem Res Toxicol 14:822-32
Rolla, R; Vay, D; Mottaran, E et al. (2000) Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology 31:878-84
McVicker, B L; Tuma, D J; Casey, C A (2000) Hyperphosphorylation of the asialoglycoprotein receptor in isolated rat hepatocytes following ethanol administration. Biochem Pharmacol 60:343-51

Showing the most recent 10 out of 68 publications